2003
DOI: 10.1016/j.jconrel.2003.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Ciprofloxacin implants for bone infection. In vitro–in vivo characterization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
60
0
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(68 citation statements)
references
References 29 publications
5
60
0
1
Order By: Relevance
“…On the protocol in which only half of the medium was replaced, concentration gradient was lower, explaining the slower CHX release kinetics over the 14 days incubation. The observed behavior is in agreement with several studies showing that controlled drug release profiles usually reveal an initial burst release of short duration that is followed by a longer period of continuous but declining release [4,13,18,[42][43][44], and that the release pattern is dependent on the amount of antimicrobial agent adsorbed on biomaterials [13,44].…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…On the protocol in which only half of the medium was replaced, concentration gradient was lower, explaining the slower CHX release kinetics over the 14 days incubation. The observed behavior is in agreement with several studies showing that controlled drug release profiles usually reveal an initial burst release of short duration that is followed by a longer period of continuous but declining release [4,13,18,[42][43][44], and that the release pattern is dependent on the amount of antimicrobial agent adsorbed on biomaterials [13,44].…”
Section: Discussionsupporting
confidence: 91%
“…CHX release results from desorption or partial dissolution of the CHX-phosphate binding. As expected, CHX release kinetics was clearly affected by the protocol used, because CHX is prone to leach, especially close to the discs' surface where rapid diffusion of water molecules was facilitated [13,4,42]. This process depends on the concentration gradient between the bulk solution and the disc surface.…”
Section: Discussionmentioning
confidence: 56%
See 1 more Smart Citation
“…PMB release in vitro began after 2 -3 days of incubation for blocks compacted at 25 m s 21 velocity and on day 5 for those compacted at 50 m s 21 (Kimakhe et al 1999). Some important results have shown the potential effectiveness of quinolones in local DDS designed to treat bone infection using carriers such as HA -anionic collagen composite (Martins & Goissis 2000), biodegradable polymers (Overbeck et al 1995;Nicolau et al 1998;Nie et al 1998;Ramchandani & Robinson 1998;Kanellakopoulou & Giamarellos-Bourboulis 2000;Désévaux et al 2002) and mixtures of calcium phosphates and biodegradable polymers (Castro et al 2003). A composite of gatifloxacine (GFLX)-loaded poly-x-caprolactone combined with x-TCP porous ceramic was obtained by compression moulding, followed by sintering (Miyai et al 2008).…”
mentioning
confidence: 99%
“…Castro et al prepared composite by simple mixing and compression (57). PLA, phosphates (Hap/TCP), and drug were mixed and pressed in carver hydraulic press at 520 or 312 MPa for 5 min.…”
Section: Compressionmentioning
confidence: 99%